<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04101461</url>
  </required_header>
  <id_info>
    <org_study_id>IDA-Obese</org_study_id>
    <nct_id>NCT04101461</nct_id>
  </id_info>
  <brief_title>The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant</brief_title>
  <official_title>The Effectiveness of Single Versus Double Daily Dose of Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anemia is known as a condition in which the hemoglobin level is lower than normal. Anemia is&#xD;
      one of the most common complications during pregnancy. Anemia in pregnancy is defined as a&#xD;
      hemoglobin level &lt; 110 g/L . Anemia is an important risk factor in pregnancy which leads to&#xD;
      both maternal and fetal morbidity and mortality.&#xD;
&#xD;
      The pregnant woman needs more iron during pregnancy, so iron deficiency anemia is very common&#xD;
      during pregnancy. In Egypt; iron deficiency anemia affects about one in every two pregnant&#xD;
      women, especially in rural areas. Pregnant women require about 27 mg/day elemental iron to&#xD;
      cover their increased need. The pregnant women should start taking a daily supplement of 30mg&#xD;
      of elemental iron as a preventive measure against iron deficiency anemia especially in poor&#xD;
      countries.&#xD;
&#xD;
      Obesity is defined as having an excessive amount of body fat. The body mass index, a&#xD;
      measurement based on height and weight, determines the obese if the figure more than 30&#xD;
      kg/m2. There is an increased rate of overweight and obesity among pregnant women. According&#xD;
      to the World Health Organization, 46% of adult females in Egypt are obese.&#xD;
&#xD;
      Many researches in the literature revealed a strong relationship between high BMI in&#xD;
      pregnancy and iron deficiency anemia. Hepcidin is an iron regulating hormone in the body.&#xD;
      Increases in iron levels in the plasma stimulate the production of hepcidin, which blocks&#xD;
      iron absorption from the diet, so; hepcidin production is suppressed in the case of iron&#xD;
      deficiency.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of anemic women at time of delivery i</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The mean level of maternal Hemoglobin at 37-38 weeks .</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of patients' reported side effect</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference in serum ferritin</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Anemia of Pregnancy</condition>
  <arm_group>
    <arm_group_label>Group I: 27 mg elemental iron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive PharaFerro27; Devart Lab Company, Egypt; once daily starting at 12 -14 weeks until 37-38 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II: 54 mg elemental iron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>will receive two tablets of PharaFerro27; Devart Lab Company, Egypt; daily starting at 12 -14 weeks until 37-38 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron</intervention_name>
    <description>PharaFerro27; Devart Lab Company, Egypt</description>
    <arm_group_label>Group I: 27 mg elemental iron</arm_group_label>
    <arm_group_label>Group II: 54 mg elemental iron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Complete blood count</intervention_name>
    <description>to assess the anemia</description>
    <arm_group_label>Group I: 27 mg elemental iron</arm_group_label>
    <arm_group_label>Group II: 54 mg elemental iron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum ferritin</intervention_name>
    <description>to assess the anemia</description>
    <arm_group_label>Group I: 27 mg elemental iron</arm_group_label>
    <arm_group_label>Group II: 54 mg elemental iron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Pregnant woman in a singleton pregnancy (12-14 weeks).&#xD;
&#xD;
          2. BMI (30- 40 kg/m2).&#xD;
&#xD;
          3. Normal hemoglobin level (&gt;11 g/dL).&#xD;
&#xD;
          4. Normal hematocrit (Hct 31-41%).&#xD;
&#xD;
          5. Normal ferritin level (6-130 ng/mL).&#xD;
&#xD;
          6. Women willingness to participate in the study.&#xD;
&#xD;
          7. Women living in the nearby area to make follow-up visits possible.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multiple gestations.&#xD;
&#xD;
          2. Women received a recent blood transfusion.&#xD;
&#xD;
          3. Women with threatened miscarriage.&#xD;
&#xD;
          4. Women are known to have pathological blood loss.&#xD;
&#xD;
          5. Intolerant to oral iron form.&#xD;
&#xD;
          6. History of the hematologic disorder.&#xD;
&#xD;
          7. Women used iron in the past 3 months.&#xD;
&#xD;
          8. Women with chronic diseases (hypertension, diabetes, renal diseases, thyroid&#xD;
             disease……).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Woman's Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed K ALi, MD</last_name>
      <phone>+201005537951</phone>
      <email>m_khairy2001@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 22, 2019</study_first_submitted>
  <study_first_submitted_qc>September 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>October 23, 2021</last_update_submitted>
  <last_update_submitted_qc>October 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

